As Washington debates how to rein in soaring prescription drug prices, including proposals that would tie U.S. prices to those paid abroad, a new study led by researchers at the Brown University School of Public Health is challenging the long-held assumption about why Americans get new medicines sooner than patients in other countries.
This article was originally published on MedicalXpress.com

